查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1994193

合約研究與生產服務市場：2026-2032年全球市場預測（按服務類型、技術、治療領域、應用和最終用戶分類）

Contract Research & Manufacturing Services Market by Service Type, Technology, Therapeutic Area, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，合約研究和製造服務市場價值將達到 765.2 億美元，到 2026 年將成長到 834 億美元，到 2032 年將達到 1507.1 億美元，複合年成長率為 10.16%。

主要市場統計數據
基準年 2025 765.2億美元
預計年份：2026年 834億美元
預測年份 2032 1507.1億美元
複合年成長率 (%) 10.16%

前瞻性的介紹概述了定義現代合約研究和製造服務的策略挑戰、營運趨勢和相關人員的期望。

合約研發和製造服務業處於科學創新、監管和商業策略的交匯點。來自產業界、學術界和政府的相關人員日益尋求能夠縮短研發週期、同時保證品質和合規性的全面解決方案。在此背景下，供應商的角色正在從單純的貿易夥伴轉變為策略合作夥伴，他們致力於降低專案風險並加速研發進程。

客戶對整合合作夥伴模式的需求正在推動產業發生顯著變革，這種模式能夠加速技術採用、監管適應和轉化研究的成功。

受技術成熟、法規演變和商業化策略轉變的驅動，合約研究和生產服務產業格局正在經歷變革性變化。先進的分析、機器學習和自動化技術正在重塑實驗室工作流程和製程開發，從而實現更高的通量和更可預測的決策。因此，將數位化工具整合到端到端開發平臺中的企業能夠提高可重複性，並加快從藥物發現到正式開發的過渡。

美國於 2025 年實施的關稅措施對營運和策略產生了累積影響，促使我們整個服務網路進行供應鏈調整、提高成本透明度並製定緊急時應對計畫。

2025年新關稅和貿易措施的實施對全球生命科學價值鏈的營運規劃和供應商關係產生了重大影響。為此，製造商和研發服務供應商正在重新思考籌資策略，重新評估供應商契約，並尋找能夠降低成本波動風險、同時維持關鍵生產能力的替代採購途徑。這些調整措施凸顯了供應商網路多元化和擴大區域採購對於管理關稅不確定性帶來的營運風險的重要性。

詳細的細分洞察揭示了服務類型、技術選擇、治療領域重點、應用要求和最終用戶概況如何決定合作夥伴選擇和交付模式。

基於細分市場的洞察揭示了相關人員在評估合作夥伴時應考慮的差異化價值提案和營運重點。從服務類型來看，服務能力涵蓋諮詢和開發、製造以及研發等領域，每個細分市場對人員、品質系統和資本投入的要求各不相同。專注於諮詢和開發的供應商通常強調科學諮詢能力和專案設計，而專注於製造的機構則優先考慮流程穩健性、產能運轉率和法規遵循。

從區域觀點全面分析美洲、歐洲、中東和非洲以及亞太地區的生產能力、監管差異和合作模式，這些因素會影響戰略部署。

區域趨勢持續影響美洲、歐洲、中東和非洲以及亞太地區的產能、監管複雜性和夥伴關係模式，每個地區都面臨各自獨特的營運權衡和戰略機會。在美洲，統一的監管流程和先進的製造生態系統支持著一體化服務模式和快速轉化項目，同時也吸引了對專業生技藥品和細胞療法能力的投資。縱觀各地區，歐洲、中東和非洲（EMEA）地區呈現出管理體制和准入途徑多元化的格局，這為擁有強大的本地監管能力和成熟臨床網路的供應商創造了有利環境。

這項關鍵的競爭考察和策略性企業洞察揭示了平台投資、夥伴關係策略和人才獲取重點如何決定合約研究和製造服務領域的領導地位。

該領域主要企業的競爭地位反映了它們在平台投資、服務廣度和地理覆蓋範圍等方面的策略重點差異。一些企業優先考慮深厚的專業知識和專有平台，這些平台能夠在生物製劑製程開發和先進分析表徵等領域提供高價值和技術差異化優勢。而其他企業則專注於服務廣度和規模，透過整合藥物發現、開發和生產能力，為複雜的專案提供一站式解決方案。

為領導者提供切實可行的策略建議，以增強韌性、加速數位轉型，並使服務交付與客戶的策略重點和監管現實保持一致。

產業領導企業應採取一系列切實可行的措施來增強韌性、實現服務差異化，並更緊密地滿足客戶需求。首先，企業需要加快將數位化工具和數據標準整合到實驗室和生產營運中，以提高可重複性並實現預測性製程控制。在進行技術現代化的同時，也應增加對員工培訓的投入，以確保分析結果能快速可靠地轉化為營運決策。

採用透明的混合方法調查方法，將對高階主管的直接訪談與系統性的二次分析結合，以檢驗見解並確保可操作的相關性。

為確保研究的深度和有效性，本分析採用了一種混合方法，將結構化的質性研究與系統性的二手資料研究結合。主要資料來源包括對高階主管、研發負責人和供應鏈專家的訪談，從而獲得關於營運挑戰、策略重點和夥伴關係模式的第一手觀點。二手資料來源包括同儕審查文獻、監管指導文件、專利申請和上市公司揭露資訊。透過綜合這些資料，我們為主題結論建立了可靠的證據基礎。

摘要強調營運卓越、數位化和諮詢型夥伴關係模式的策略整合將決定未來的成功。

總之，合約研究與生產服務 (CR&M) 產業正處於一個關鍵的轉折點，其特點是技術快速變革、監管預期不斷變化以及客戶對整合式諮詢型夥伴關係關係的需求日益成長。那些在數位化平台、人才培養和供應鏈韌性方面進行合理投資的機構，將更有能力應對不確定性，並在各個治療領域建立策略聯盟。此外，能夠提供清晰、可審計的數據並協調不同司法管轄區的品質體系，正日益成為一項重要的競爭優勢，也是建立長期客戶信任的基礎。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 合約研究與製造服務市場：依服務類型分類

  • 諮詢
  • 發展
  • 製造業
  • 調查

第9章 合約研究與製造服務市場：依技術分類

  • 生物資訊學
  • 組合化學
  • 高通量篩檢
  • 光譜學

第10章：合約研究與製造服務市場：依治療領域分類

  • 循環系統
  • 內分泌疾病
  • 感染疾病
  • 腫瘤學

第11章 合約研究與製造服務市場：依應用領域分類

  • 生物製藥開發
  • 藥物發現
  • 配方開發
  • 製程開發

第12章 合約研究與製造服務市場：依最終用戶分類

  • 學術和研究機構
  • 生技公司
  • 醫療設備製造商
  • 製藥公司

第13章 合約研究與製造服務市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 合約研究與製造服務市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 合約研究與製造服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國合約研究與製造服務市場

第17章：中國的合約研究與製造服務市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AGC Biologics
  • Avid Bioservices, Inc.
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent, Inc.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • Envigo
  • Eurofins Scientific SE
  • Fujifilm Diosynth Biotechnologies
  • Gubra A/S
  • ICON plc
  • IQVIA Holdings Inc.
  • LabCorp Drug Development
  • Lonza Group Ltd
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • Pharmaceutical Product Development, LLC（PPD）
  • Recipharm AB
  • Samsung Biologics Co., Ltd.
  • Sartorius Stedim Biotech SA
  • Siegfried AG
  • Syneos Health, Inc.
  • TFBS Bioscience Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
Product Code: MRR-1A1A064C0470

The Contract Research & Manufacturing Services Market was valued at USD 76.52 billion in 2025 and is projected to grow to USD 83.40 billion in 2026, with a CAGR of 10.16%, reaching USD 150.71 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 76.52 billion
Estimated Year [2026] USD 83.40 billion
Forecast Year [2032] USD 150.71 billion
CAGR (%) 10.16%

A forward-looking introduction framing the strategic imperatives, operational dynamics, and stakeholder expectations that define modern contract research and manufacturing services

The contract research and manufacturing services sector operates at the intersection of scientific innovation, regulatory scrutiny, and commercial strategy. Stakeholders across industry, academia, and government increasingly demand integrated solutions that shorten development timelines while maintaining quality and regulatory compliance. In this context, service providers are evolving from transactional vendors into strategic partners that contribute to program de-risking and accelerated development pathways.

Emerging technological capabilities and shifting client expectations are reinforcing the need for versatile operating models. Organizations are balancing investments in specialized platforms with flexible capacity to serve diverse therapeutic programs. This introduction frames the critical themes explored in the subsequent sections, emphasizing a pragmatic view of risk management, collaborative engagement models, and the operational imperatives that will determine competitive differentiation in the near to medium term.

Compelling landscape shifts driven by technology adoption, regulatory adaptation, and client demand for integrated partner models that accelerate translational success

The landscape of contract research and manufacturing services is undergoing transformative shifts driven by technological maturation, regulatory evolution, and changing commercialization strategies. Advanced analytics, machine learning, and automation are reshaping laboratory workflows and process development, enabling higher throughput and more predictive decision-making. Consequently, organizations that integrate digital tools into end-to-end development pipelines are realizing improved reproducibility and faster handoffs from discovery to formal development stages.

Concurrently, regulatory frameworks are adapting to novel modalities and accelerated approval pathways, placing a premium on demonstrable quality and data integrity. This regulatory evolution has prompted service providers to embed compliance expertise earlier in program design and to offer harmonized documentation practices that support multi-jurisdictional submissions. In parallel, client expectations have shifted toward partner models that combine technical execution with strategic advisory capabilities, leading to bundled service offerings that span discovery, formulation, process development, and scale-up. Taken together, these trends are compelling firms to invest in both technological platforms and consultative talent, so they can deliver predictable outcomes across increasingly complex therapeutic portfolios.

Cumulative operational and strategic consequences of United States tariff actions in 2025 driving supply chain rebalancing, cost transparency, and contingency planning across service networks

The introduction of new tariffs and trade measures in 2025 has materially affected operational planning and supplier relationships across global life sciences supply chains. Manufacturers and research service providers have responded by reassessing sourcing strategies, re-evaluating supplier contracts, and identifying alternative procurement routes that can mitigate cost volatility while preserving critical capacity. These adaptations have emphasized the value of diversified supplier networks and increased regional sourcing to manage the operational exposure created by tariff uncertainty.

In parallel, clients have prioritized transparency around landed costs and supply chain continuity, prompting service providers to present more granular cost breakdowns and contingency plans. Firms with flexible manufacturing footprints and multi-jurisdictional regulatory expertise have gained an advantage when clients seek rapid adjustments to development or manufacturing plans. Furthermore, organizations are increasingly embedding tariff scenario planning into project timelines and capital allocation exercises, ensuring that procurement and program leadership collaborate closely to preserve timelines and maintain regulatory alignment despite evolving trade constraints.

In-depth segmentation insights illuminating how service types, technology choices, therapeutic focus, application requirements, and end-user profiles determine partner selection and delivery models

Segmentation-driven insights reveal differentiated value propositions and operational priorities that stakeholders should consider when evaluating partners. When viewed through the lens of service type, capabilities span a continuum from consulting and development to manufacturing and research, with each segment demanding distinct talent, quality systems, and capital intensity. Providers focusing on consulting and development typically emphasize scientific advisory capabilities and program design, whereas manufacturing-focused organizations prioritize process robustness, capacity utilization, and regulatory readiness.

Technology-based segmentation underscores how platform choices shape service delivery. Bioinformatics, combinatorial chemistry, high-throughput screening, and spectroscopy each contribute unique data streams and workflow needs; integrating these platforms requires interoperable data architectures and cross-disciplinary expertise. Therapeutic area segmentation highlights clinical and regulatory nuances across cardiovascular, endocrine disease, infectious disease, and oncology programs, informing required safety assessments and specialized process controls. Application-focused segmentation draws attention to the differing priorities of biologics development, drug discovery, formulation development, and process development, with each application imposing its own timeline, analytical demand, and manufacturing constraints. Finally, end-user segmentation recognizes the diverse buying behaviors and operational objectives of academic and research institutes, biotechnology companies, medical device companies, and pharmaceutical companies, whereby academic partners may prioritize flexibility and novel science, small biotech may emphasize speed to proof-of-concept, and larger pharma partners often require scale, documented control strategies, and integrated regulatory support.

Comprehensive regional perspectives on capacity, regulatory variation, and collaborative models across the Americas, Europe, Middle East & Africa, and Asia-Pacific influencing strategic deployment

Regional dynamics continue to influence capacity, regulatory complexity, and partnership models across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each geography presenting distinct operational trade-offs and strategic opportunities. In the Americas, centralized regulatory pathways and advanced manufacturing ecosystems often support integrated service models and rapid translational programs, while also attracting investment in specialized biologics and cell therapy capabilities. Transitioning across regions, the Europe, Middle East & Africa cluster presents a mosaic of regulatory regimes and access pathways that favor providers with strong local regulatory affairs capabilities and established clinical networks.

Asia-Pacific has emerged as a critical node for both development and manufacturing due to investments in talent, scale capacity, and cost-competitive production. As a result, many organizations pursue hybrid strategies that combine regional development hubs with localized manufacturing to optimize speed-to-market and manage regulatory submissions in multiple jurisdictions. Across all regions, cross-border collaboration and harmonization efforts are increasing, which encourages service providers to standardize quality systems and to offer coordinated regulatory support that reduces duplicative work and accelerates global program timelines.

Key competitive and strategic company insights revealing how platform investments, partnership strategies, and talent priorities define leadership in contract research and manufacturing services

Competitive positioning among leading firms in the sector reflects differing strategic emphases on platform investments, service breadth, and geographic reach. Some organizations prioritize deep specialization and proprietary platforms that deliver high-value, technical differentiation in areas such as biologics process development or advanced analytical characterization. Other firms emphasize breadth of service and scale, bundling discovery, development, and manufacturing capabilities to offer a single-source solution for complex programs.

Partnership strategies are increasingly common, as firms form alliances with technology vendors, academic centers, and contract partners to close capability gaps and to accelerate time to clinic. Talent acquisition and retention remain central competitive levers; companies that invest in cross-functional scientists and regulatory experts can more effectively support customers through complex development pathways. Additionally, firms that cultivate transparent client communication practices and robust quality systems tend to secure longer-term collaborations, as clients prioritize predictability and regulatory readiness when selecting partners.

Actionable strategic recommendations for leaders to enhance resilience, accelerate digital transformation, and align service delivery with client strategic priorities and regulatory realities

Industry leaders should adopt a set of pragmatic, actionable measures to strengthen resilience, differentiate their offerings, and align more closely with client needs. First, companies should accelerate integration of digital tools and data standards into laboratory and manufacturing operations to enhance reproducibility and enable predictive process control. This technical modernization should be accompanied by investments in workforce training so that teams can translate analytic outputs into operational decisions quickly and reliably.

Second, firms should formalize multi-scenario supply chain planning that anticipates tariff shifts, regulatory variations, and capacity constraints; by doing so, they can reduce program disruption and improve cost visibility for clients. Third, service providers should expand consultative capabilities that embed regulatory and commercial strategy into project design, thereby delivering more strategic value than project execution alone. Finally, organizations should pursue selective partnerships to access niche technologies or regional capacity, while maintaining a rigorous governance framework to ensure quality alignment and seamless data transfer across collaborative arrangements.

Transparent mixed-method research methodology combining primary executive interviews and systematic secondary analysis to validate insights and ensure practical relevance

The research underpinning this analysis used a mixed-method approach that combined structured qualitative inquiry with systematic secondary research to ensure depth and validity. Primary inputs included interviews with senior executives, R&D leaders, and supply chain specialists who provided firsthand perspectives on operational challenges, strategic priorities, and partnership models. Secondary inputs comprised peer-reviewed literature, regulatory guidance documents, patent filings, and public company disclosures, which together established a robust evidentiary basis for thematic conclusions.

Data synthesis emphasized triangulation to reduce single-source bias, and analytic frameworks were applied to map capabilities across service, technology, therapeutic, application, and end-user dimensions. Wherever possible, findings were corroborated through multiple independent sources and validated with industry practitioners to ensure practical relevance. The methodology prioritized transparency in assumptions and traceability of insights to source material, thereby facilitating confident interpretation and application by decision-makers.

Concluding synthesis emphasizing the strategic convergence of operational excellence, digital enablement, and consultative partnership models that will define future success

In closing, the contract research and manufacturing services sector is at a pivotal moment characterized by rapid technological change, evolving regulatory expectations, and heightened client demand for integrated, consultative partnerships. Organizations that align investments in digital platforms, talent development, and supply chain resilience will be better positioned to navigate uncertainty and to capture strategic collaborations across therapeutic areas. Moreover, the ability to present clear, auditable data and to harmonize quality systems across jurisdictions is increasingly a competitive differentiator that underpins long-term client trust.

Looking ahead, success will favor firms that combine operational excellence with advisory capabilities, enabling clients to progress complex programs more predictably. By focusing on interoperability of data systems, rigorous scenario planning, and selective partnerships for capability expansion, stakeholders can create more adaptable, value-driven service models that respond effectively to scientific and regulatory change.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Contract Research & Manufacturing Services Market, by Service Type

  • 8.1. Consulting
  • 8.2. Development
  • 8.3. Manufacturing
  • 8.4. Research

9. Contract Research & Manufacturing Services Market, by Technology

  • 9.1. Bioinformatics
  • 9.2. Combinatorial Chemistry
  • 9.3. High-Throughput Screening
  • 9.4. Spectroscopy

10. Contract Research & Manufacturing Services Market, by Therapeutic Area

  • 10.1. Cardiovascular
  • 10.2. Endocrine disease
  • 10.3. Infectious disease
  • 10.4. Oncology

11. Contract Research & Manufacturing Services Market, by Application

  • 11.1. Biologics Development
  • 11.2. Drug Discovery
  • 11.3. Formulation Development
  • 11.4. Process Development

12. Contract Research & Manufacturing Services Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Biotechnology Companies
  • 12.3. Medical Device Companies
  • 12.4. Pharmaceutical Companies

13. Contract Research & Manufacturing Services Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Contract Research & Manufacturing Services Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Contract Research & Manufacturing Services Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Contract Research & Manufacturing Services Market

17. China Contract Research & Manufacturing Services Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AGC Biologics
  • 18.6. Avid Bioservices, Inc.
  • 18.7. Boehringer Ingelheim International GmbH
  • 18.8. Cambrex Corporation
  • 18.9. Catalent, Inc.
  • 18.10. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 18.11. Envigo
  • 18.12. Eurofins Scientific SE
  • 18.13. Fujifilm Diosynth Biotechnologies
  • 18.14. Gubra A/S
  • 18.15. ICON plc
  • 18.16. IQVIA Holdings Inc.
  • 18.17. LabCorp Drug Development
  • 18.18. Lonza Group Ltd
  • 18.19. Medpace Holdings, Inc.
  • 18.20. Parexel International Corporation
  • 18.21. Pharmaceutical Product Development, LLC (PPD)
  • 18.22. Recipharm AB
  • 18.23. Samsung Biologics Co., Ltd.
  • 18.24. Sartorius Stedim Biotech S.A.
  • 18.25. Siegfried AG
  • 18.26. Syneos Health, Inc.
  • 18.27. TFBS Bioscience Inc.
  • 18.28. Thermo Fisher Scientific Inc.
  • 18.29. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ENDOCRINE DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ENDOCRINE DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ENDOCRINE DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOLOGICS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOLOGICS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOLOGICS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY FORMULATION DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY FORMULATION DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. GCC CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 151. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA CONTRACT RESEARCH & MANUFACTURING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)